Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02809846 · ClinicalTrials.gov registry record · NA
Quell Opioid Reduction and Pain Relief in Patients With Cancer
A NA study, sponsored by Scripps Translational Science Institute.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02809846 is a NA study that was terminated before completion, run by Scripps Translational Science Institute. The registered enrollment target is 33 participants.
The verdict
NCT02809846, a NA study, was terminated before completion, sponsored by Scripps Translational Science Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
To study effects the Quell device has on opioid consumption and pain relief in patients with cancer.
Interventions
- DEVICE Quell
- DEVICE Sham Quell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02809846
The ClinicalTrials.gov registry entry for NCT02809846 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quell is the first listed.
NCT02809846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02809846 about?
NCT02809846 is a clinical study titled "Quell Opioid Reduction and Pain Relief in Patients With Cancer". To study effects the Quell device has on opioid consumption and pain relief in patients with cancer.
What is the current status of trial NCT02809846?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2016-07. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02809846?
The interventions under investigation include: Quell (DEVICE), Sham Quell (DEVICE).
Who is sponsoring clinical trial NCT02809846?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.